Precision Oncology Symposium

The Precision Oncology Symposium, presented by ANCO and MOASC, is a significant gathering aimed at enhancing the understanding and application of precision oncology in cancer treatment. This event will take place at the InterContinental San Francisco, where clinicians will have the opportunity to explore the latest advancements in molecular diagnostic profiling and individualized treatment recommendations. With recent FDA approvals highlighting the importance of molecular tumor features over traditional disease classifications, this symposium promises to be at the forefront of cancer care innovation. Attendees can expect to engage with cutting-edge technologies that are reshaping clinical practices in oncology.In addition to the educational component, the symposium fosters a collaborative environment, allowing industry representatives to connect with key stakeholders in the cancer care community. ANCO's Industry Registration policy ensures that a diverse range of participants can attend, with limited representation from companies not exhibiting at the event. This approach encourages meaningful interactions among oncologists and industry professionals, reinforcing ANCO's role as a critical resource for local oncologists and a bridge to national organizations like ASCO. The event emphasizes the importance of community engagement and local expertise in advancing cancer research and treatment strategies.